182 related articles for article (PubMed ID: 35275541)
1. Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.
Krause-Sorio B; Siddarth P; Kilpatrick L; Milillo MM; Aguilar-Faustino Y; Ercoli L; Narr KL; Khalsa DS; Lavretsky H
J Alzheimers Dis; 2022; 87(2):569-581. PubMed ID: 35275541
[TBL] [Abstract][Full Text] [Related]
2. Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
Kilpatrick LA; Siddarth P; Krause-Sorio B; Milillo MM; Aguilar-Faustino Y; Ercoli L; Narr KL; Khalsa DS; Lavretsky H
J Alzheimers Dis; 2023; 95(1):149-159. PubMed ID: 37482992
[TBL] [Abstract][Full Text] [Related]
3. Cognitive and immunological effects of yoga compared to memory training in older women at risk for alzheimer's disease.
Grzenda A; Siddarth P; Milillo MM; Aguilar-Faustino Y; Khalsa DS; Lavretsky H
Transl Psychiatry; 2024 Feb; 14(1):96. PubMed ID: 38355715
[TBL] [Abstract][Full Text] [Related]
4. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of Kundalini yoga in mild cognitive impairment.
Eyre HA; Siddarth P; Acevedo B; Van Dyk K; Paholpak P; Ercoli L; St Cyr N; Yang H; Khalsa DS; Lavretsky H
Int Psychogeriatr; 2017 Apr; 29(4):557-567. PubMed ID: 28088925
[TBL] [Abstract][Full Text] [Related]
6. Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study.
Wan K; Yin W; Tang Y; Zhu W; Wang Z; Zhou X; Zhang W; Zhang C; Yu X; Zhao W; Li C; Zhu X; Sun Z
J Alzheimers Dis; 2023; 92(1):81-93. PubMed ID: 36710682
[TBL] [Abstract][Full Text] [Related]
7. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
He P; Qu H; Cai M; Liu W; Gu X; Ma Q
Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort.
Chaudhary S; Zhornitsky S; Chao HH; van Dyck CH; Li CR
J Alzheimers Dis; 2022; 85(3):1251-1265. PubMed ID: 34924392
[TBL] [Abstract][Full Text] [Related]
11. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
[TBL] [Abstract][Full Text] [Related]
13. Altered mismatch response precedes gray matter atrophy in subjective cognitive decline.
Cheng CH; Chang CC; Chao YP; Lu H; Peng SW; Wang PN
Psychophysiology; 2021 Jun; 58(6):e13820. PubMed ID: 33792049
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
[TBL] [Abstract][Full Text] [Related]
15. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
[TBL] [Abstract][Full Text] [Related]
16. Predicting the apolipoprotein E ε4 allele carrier status based on gray matter volumes and cognitive function.
Kim HG; Tian Y; Jung SM; Park S; Rhee HY; Ryu CW; Jahng GH
Brain Behav; 2024 Jan; 14(1):e3381. PubMed ID: 38376028
[TBL] [Abstract][Full Text] [Related]
17. Smaller grey matter volume in the central olfactory system in mild cognitive impairment.
Jobin B; Boller B; Frasnelli J;
Exp Gerontol; 2023 Nov; 183():112325. PubMed ID: 37952649
[TBL] [Abstract][Full Text] [Related]
18. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
[TBL] [Abstract][Full Text] [Related]
19. Functional and structural alterations of dorsal attention network in preclinical and early-stage Alzheimer's disease.
Wu H; Song Y; Yang X; Chen S; Ge H; Yan Z; Qi W; Yuan Q; Liang X; Lin X; Chen J
CNS Neurosci Ther; 2023 Jun; 29(6):1512-1524. PubMed ID: 36942514
[TBL] [Abstract][Full Text] [Related]
20. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
